Vol 11, No 2 (2013)
Review paper
Published online: 2013-12-10
Page views
1248
Article views/downloads
21819
Avanafil — new drug for treatment of erectile dysfunction
Seksuologia Polska 2013;11(2).
Abstract
Phosphodiesterase type 5 inhibitors are currently the first-choice drugs for treatment of erectile dysfunction. Avanafil is a novel phosphodiesterase type 5 inhibitor. The drug is characterized by the fast onset of action, higher selectivity, better efficacy and lower rates of side effects. It should be administered in dose of 50 mg to 200 mg. Avanafil is associated with more spontaneous sexual activity.
Keywords: avanafilerectile dysfunctionphosphodiesterase type 5 inhibitors
